10-K

Company

REGENERON PHARMACEUTICALS, INC.

Filed

February 27, 2008

Period of Report

December 31, 2007

Accession Number

0000950123-08-002191

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →